TARGET AUDIENCE
This educational activity is intended for HCPs who care for patients with T2D, including primary care providers (MD/DOs), including those who specialize in family practice, as well as advanced practice professionals (nurse practitioners and PAs).

PROGRAM OVERVIEW
The goal of this activity is to educate health care professionals about current issues related to type 2 diabetes. This education will provide an overview and differentiation of currently available GLP-1 RAs to manage this disease, including mechanism of action, dosing optimization and administration, glycemic and extra-glycemic effects, safety and tolerability concerns, and early place in therapy according to treatment guidelines.

Through content-based questions, reflection statements, and clinical case scenarios, learners will apply the information and strategies provided in this education to demonstrate improved confidence and abilities to:

• Differentiate available GLP-1 RAs based on therapy characteristics
• Utilize patient preferences and available treatment guidelines to select optimal GLP-1 RA for patients with T2D
• Implement strategies to manage potential side effects of GLP-1 RAs in the management of T2D

FACULTY

Jay Shubrook, DO
Professor, Primary Care Department, College of Osteopathic Medicine
Touro University
Vallejo, CA

Leslie Goldstein, PharmD
Associate Professor of Pharmacology
New York Institute of Technology
New York, NY

PLANNING COMMITTEE

Jay Shubrook, DO
Professor, Primary Care Department, College of Osteopathic Medicine
Touro University
Vallejo, CA

Leslie Goldstein, PharmD
Associate Professor of Pharmacology
New York Institute of Technology
New York, NY

This activity is jointly provided by The France Foundation, the American College of Osteopathic Family Physicians (ACOFP), and the California Academy of Family Physicians (CAFP).

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by The France Foundation, the American College of Osteopathic Family Physicians (ACOFP), and the California Academy of Family Physicians (CAFP). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

CAFP is an AAFP Credit System authorized provider. CAFP has been recognized by the Accreditation Council for Continuing Medical Education (ACCME) as an exemplary provider of CME achieving Accreditation with Commendation since 2007.

CREDIT DESIGNATION

Physicians
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACOFP designates this enduring activity for a maximum of 1.0 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this activity.

California Academy of Family Physicians designates this activity for a maximum of 1.0 AAFP Prescribed Credits.

Nurses

The France Foundation designates this activity for 1.0 contact hours.

Physician Assistants

The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 10/09/24. PAs should only claim credit commensurate with the extent of their participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF), The American College of Osteopathic Family Physicians (ACOFP), and The California Academy of Family Physicians (CAFP) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF, ACOFP, and CAFP resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF, ACOFP, and CAFP seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF, ACOFP, and CAFP are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF, ACOFP, and CAFP require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF, ACOFP, and CAFP do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an independent medical educational grant from Novo Nordisk.

TFF, ACOFP, and CAFP present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. TFF, ACOFP, CAFP and the commercial supporter(s) assume no liability for the information herein.

Copyright © 2023 The France Foundation, California Academy of Family Physicians, and American College of Osteopathic Family Physicians. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission